山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (3): 76-82.doi: 10.6040/j.issn.1671-7554.0.2021.0660
钟黎黎1,盛莹1,郭江虹1,阳双健1,何宜静2
ZHONG Lili1, SHENG Ying1, GUO Jianghong1, YANG Shuangjian1, HE Yijing2
摘要: 目的 探讨长链非编码RNA尿道上皮癌相关基因1(LncRNA-UCA1)对滋养细胞侵袭与转移的影响及其可能机制。 方法 收集30例行剖宫产分娩的子痫前期(PE)患者胎盘组织和30例正常妊娠孕妇胎盘组织,qRT-PCR检测各胎盘组织中UCA1和miR-182-5p表达水平。以滋养细胞HTR-8/Svneo为研究对象,将UCA1过表达质粒(pcDNA3.1-UCA1)及其空载质粒(Vector)转染至细胞中,qRT-PCR检测细胞中UCA1和miR-182-5p表达水平;采用双荧光素酶报告基因实验验证UCA1与miR-182-5p之间的靶向调控关系。将pcDNA3.1-UCA1质粒与miR-182-5p mimic分别或同时转染至HTR-8/Svneo细胞中,CCK-8检测细胞增殖活性;Transwell实验检测细胞侵袭与转移;Western blotting检测基质金属蛋白酶-2(MMP-2)和MMP-9蛋白表达变化。 结果 (1)临床标本测定结果:与正常妊娠孕妇胎盘组织比较,PE患者胎盘组织中UCA1表达降低(1.10±0.51 vs 5.74±1.63),差异有统计学意义(t =14.947,P<0.001),而miR-182-5p表达显著增加(7.23±1.44 vs 1.07±0.72),差异有统计学意义(t=20.961,P<0.001)。(2)细胞实验结果:UCA1能特异性靶向调控miR-182-5p表达。与Vector组比较,UCA1过表达可降低HTR-8/SVneo细胞中miR-182-5p表达(0.12±0.05 vs 0.97±0.06,t=19.028,P<0.001),促进细胞增殖、侵袭和迁移(t=10.160、17.228、13.768,P均<0.001),并上调MMP-2和MMP-9蛋白表达(t=20.833、24.793,P均<0.001);而miR-182-5p过表达能显著减弱UCA1过表达对HTR-8/SVneo细胞增殖、侵袭和迁移的促进作用。 结论 UCA1通过靶向下调miR-182-5p表达促进滋养细胞侵袭与转移。
中图分类号:
| [1] Macuácua S, Catalão R, Sharma S, et al. Policy review on the management of pre-eclampsia and eclampsia by community health workers in Mozambique[J]. Hum Resour Health, 2019, 17(1): 15. [2] Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications[J]. BMJ, 2019, 366: l2381. doi: 10.1136/bmj.l2381. [3] McClements L, Richards C, Patel N, et al. Impact of reduced uterine perfusion pressure model of preeclampsia on metabolism of placenta, maternal and fetal hearts[J]. Sci Rep, 2022, 12(1): 1111. [4] Kawasaki K, Kondoh E, Chigusa Y, et al. Metabolomic profiles of placenta in preeclampsia[J]. Hypertension, 2019, 73(3): 671-679. [5] Kim GS, Hwang KA, Choi KC. A promising therapeutic strategy for metastatic gestational trophoblastic disease: engineered anticancer gene-expressing stem cells to selectively target choriocarcinoma[J]. Oncol Lett, 2019, 17(3): 2576-2582. [6] 李思维, 庞达. 长链非编码RNA(lncRNA)在癌症中的作用[J]. 实用肿瘤学杂志, 2019, 33(5): 471-475. LI Siwei, PANG Da. Long non-coding RNA(lncRNA)role in cancer [J]. Practical Oncology Journal, 2019, 33(5): 471-475. [7] Khawar MB, Hamid SE, Jan T, et al. Diagnostic, prognostic and therapeutic potential of long noncoding RNAs in cancer[J]. Mol Biol Rep, 2022. doi: 10.1007/s11033-022-07180-z. [8] Wang F, Li X, Xie XJ, et al. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion[J]. FEBS Lett, 2008, 582(13): 1919-1927. [9] Yao F, Wang Q, Wu Q. The prognostic value and mechanisms of lncRNA UCA1 in human cancer[J]. Cancer Manag Res, 2019, 11: 7685-7696. doi: 10.2147/CMAR.S200436. [10] Fang YN, Huang ZL, Li H, et al. Highly expressed miR-182-5p can promote preeclampsia progression by degrading RND3 and inhibiting HTR-8/SVneo cell invasion[J]. Eur Rev Med Pharmacol Sci, 2018, 22(20): 6583-6590. [11] Abu-Dief EE, Elsayed HM, Atia EW, et al. Modulation of telocytes in women with preeclampsia: a prospective comparative study[J]. J Microsc Ultrastruct, 2021, 9(4): 158-163. [12] Ibanoglu MC, Oskovi-Kaplan ZA, Ozgu-Erdinc AS, et al. Comparison of the Kisspeptin levels in early onset preeclampsia and late-onset preeclampsia[J]. Arch Gynecol Obstet, 2022. doi: 10.1007/s00404-021-06359-2. [13] 吴秋雨,郇金亮. 颗粒蛋白前体通过调控滋养层细胞的侵袭和凋亡影响子痫前期发病[J]. 第三军医大学学报, 2018, 40(20): 1858-1864. WU Qiuyu, HUAN Jinliang. Progranulin may suppress preeclampsia by promoting invasion and apoptosis of trophoblast cells [J]. Acta Academiae Medicinae Militaris Tertiae, 2018, 40(20): 1858-1864. [14] Song X, Luo X, Gao Q, et al. Dysregulation of lncRNAs in placenta and pathogenesis of preeclampsia[J]. Curr Drug Targets, 2017, 18(10): 1165-1170. [15] Munjas J, Sopi c M, Stefanovi c A, et al. Non-coding RNAs in preeclampsia-molecular mechanisms and diagnostic potential[J]. Int J Mol Sci, 2021, 22(19): 10652. [16] Sun N, Qin S, Zhang L, et al. Roles of noncoding RNAs in preeclampsia[J]. Reprod Biol Endocrinol, 2021, 19(1): 100. [17] He X, He Y, Xi B, et al. LncRNAs expression in preeclampsia placenta reveals the potential role of LncRNAs contributing to preeclampsia pathogenesis[J]. PLoS One, 2013, 8(11): e81437. [18] 刘沙沙,左俊芳,崔洪艳.长链非编码RNA与子痫前期相关机制的研究进展[J].国际妇产科学杂志, 2018, 45(3): 250-253. LIU Shasha, ZUO Junfang, CUI Hongyan. Advances in the association between LncRNAs and preeclampsia [J]. Guoji Fuchankexue Zazhi, 2018, 45(3): 250-253. [19] Sun MD, Zheng YQ, Wang LP, et al. Long noncoding RNA UCA1 promotes cell proliferation, migration and invasion of human leukemia cells via sponging miR-126[J]. Eur Rev Med Pharmacol Sci, 2018, 22(8): 2233-2245. [20] Fang Q, Chen X, Zhi X. Long non-coding RNA(LncRNA)urothelial carcinoma associated 1(UCA1)increases multi-drug resistance of gastric cancer via downregulating miR-27b[J]. Med Sci Monit, 2016, 22: 3506-3513. doi: 10.12659/msm.900688. [21] Fang YN, Huang ZL, Li H, et al. Highly expressed miR-182-5p can promote preeclampsia progression by degrading RND3 and inhibiting HTR-8/SVneo cell invasion[J]. Eur Rev Med Pharmacol Sci, 2018, 22(20): 6583-6590. [22] Zhang M, Zhao Y, Zhang Y, et al. LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(5 Pt A): 1770-1782. [23] Xie F, Li Y, Wang M, et al. Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis[J]. Mol Cancer, 2018, 17(1): 144. [24] 丰琳,李炎.子痫前期产妇血清MMP2、MMP9含量检测及胎盘床血流动力学异常情况评估[J].海南医学院学报, 2015, 21(1): 111-113. FENG Lin, LI Yan. MMP2, MMP9 content in preeclampsia maternal serum and placental bed hemodynamic abnormality evaluation [J]. Journal of Hainan Medical University, 2015, 21(1): 111-113. [25] Zhang SM, Tian FJ, Zeng WH, et al. XCL1-XCR1 pathway promotes trophoblast invasion at maternal-fetal interface by inducing MMP-2/MMP-9 activity[J]. Am J ReprodImmunol, 2018, 80(3): e12990. [26] Plaks V, Rinkenberger J, Dai J, et al. Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction[J]. Proc Natl Acad Sci U S A, 2013, 110(27): 11109-11114. |
| [1] | 殷悦,莫振飞,吴培昕,刘金霞,魏元辉,任佳博,李春笋. GPX1基因在肺癌中的表达特征及其对肺腺癌细胞增殖、迁移、侵袭、凋亡的影响[J]. 山东大学学报 (医学版), 2026, 64(1): 65-73. |
| [2] | 李梓绮,魏闫若雪,刘晓晗,刘春铖,赵然,刘玉昆. 长链非编码RNA HEATR3反义RNA 1参与结直肠癌发生发展的功能及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(9): 108-115. |
| [3] | 韩觉明,王晖,吴倩,郑慧玲,朱琳. B4GALNT4促进肺腺癌细胞增殖、迁移和侵袭能力[J]. 山东大学学报 (医学版), 2025, 63(7): 23-31. |
| [4] | 张洁,赵颖慧,董雅琪,李娟,李培龙,杜鲁涛. GPR133基因甲基化在早期胃癌淋巴结转移预测中的作用[J]. 山东大学学报 (医学版), 2025, 63(3): 76-84. |
| [5] | 刘振昆,吕纪玲,徐伟伟,马力天,张才擎. BALF tNGS检测及培养对NSCLC合并IPFD的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(11): 36-45. |
| [6] | 张洁,张芳芳,王靖楠,李泽宇,宋颖,李娜. circ_0000144在乳腺癌中的表达及其对乳腺癌细胞增殖、迁移和侵袭能力的影响[J]. 山东大学学报 (医学版), 2025, 63(1): 35-42. |
| [7] | 孙婧,杨瑞敏,王聪,张月,罗兵. 基于术前超声、炎症指标及超声影像组学联合模型预测乳腺癌腋窝淋巴结转移[J]. 山东大学学报 (医学版), 2025, 63(1): 73-80. |
| [8] | 张展,李建锋,李燕玲,王博雯,昂文成林龙珠,王鑫,张小明,谢萍. 饮食因素与子痫前期因果关系的孟德尔随机化分析[J]. 山东大学学报 (医学版), 2024, 62(8): 59-66. |
| [9] | 张学宇,张学海,孙文青,刘晗,姜金波,刘寒,李远,陈晓梅. 重症新型冠状病毒肺炎伴侵袭性肺曲霉病及反复致命性消化道出血1例[J]. 山东大学学报 (医学版), 2024, 62(7): 56-61. |
| [10] | 宋艳艳,左淑英. 透明细胞肾细胞癌颌下腺转移1例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(7): 120-124. |
| [11] | 林雨洋,王蓓,李菲. 大于10 mm甲状腺乳头状癌侧颈区淋巴结转移预测[J]. 山东大学学报 (医学版), 2024, 62(6): 54-64. |
| [12] | 刘爱静,李雁儒,高惠茹,段伟丽,李培龙,李娟,杜鲁涛,王传新. 自噬相关蛋白5在结肠癌中的表达及对结肠癌细胞迁移及侵袭能力的影响[J]. 山东大学学报 (医学版), 2024, 62(4): 14-23. |
| [13] | 吴霖,石晨曦,童星. 肺良性转移性平滑肌瘤病7例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(4): 78-84. |
| [14] | 秦金金,曹辰媛,邢杰杰,安燕,黄煜湘. 子痫前期相关Siglec-6核心基因的预测及生物信息学分析[J]. 山东大学学报 (医学版), 2024, 62(1): 31-37. |
| [15] | 孙菁果,朱文帅,鲁艺,马晓丽,郏雁飞. 幽门螺杆菌感染对胃癌细胞m6A水平的影响及其机制[J]. 山东大学学报 (医学版), 2023, 61(9): 10-18. |
|
||